PHARMAC seeks clinical feedback on its cost-utility analysis methodology

N Z Med J. 2006 Aug 4;119(1239):U2113.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cost-Benefit Analysis / methods
  • Drug and Narcotic Control*
  • Economics, Pharmaceutical*
  • Humans
  • New Zealand